LEAH JOHNSTON: Open Payments
NPI 1487278842 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,216 in 108 payments from 17 companies in 2025. Trend: 2023 $1,128 · 2024 $1,278 · 2025 $2,216
Food & beverage: $2,168Education: $48
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $350 |
| Axsome Therapeutics, Inc. | 10 | $304 |
| Teva Pharmaceuticals USA, Inc. | 6 | $242 |
| Alkermes, Inc. | 11 | $227 |
| Otsuka America Pharmaceutical, Inc. | 15 | $216 |
| E.R. Squibb & Sons, L.L.C. | 4 | $161 |
| Corium, LLC | 11 | $126 |
| Neurocrine BioSciences, Inc. | 4 | $109 |
| Vanda Pharmaceuticals Inc. | 4 | $100 |
| Lundbeck LLC | 4 | $92 |
Products named: VRAYLAR, Auvelity, REXULTI, UZEDY, COBENFY, Azstarys, ARISTADA, INGREZZA.
Industry payments across TX — which companies pay providers there.
